Institute of the History, Philosophy and Ethics of Medicine, Ulm University, Ulm, Germany.
Front Public Health. 2021 Nov 25;9:797838. doi: 10.3389/fpubh.2021.797838. eCollection 2021.
For group-based participatory interventions in the context of occupational health, no questionnaires exist to assess the participants' active engagement in the interventions. On the basis of the construct of collective efficacy beliefs, this study has developed a questionnaire with which the group-related efficacy beliefs can be assessed as a precondition for participants actively engaging in participative interventions. Participants were drawn from a two-arm cluster-randomized intervention study to fill out the questionnaire. A Factor analysis and an initial psychometric calibration were performed. In a second step, the group-related properties of the questionnaire were validated using a Multilevel analysis. The factorial structure of the questionnaire is consistent with the theory of efficacy beliefs according to A. Bandura. Furthermore, the collective efficacy expectations of the interventions' participants are lowered in the absence of appreciation and support in the psychosocial environment of the worksite. Assessing participant's quality of interventional activity in participatory interventions by collective efficacy can be valuable in understanding the amount of interventional activity. In addition, it is recommended to consider the influence of the worksite's psychosocial environment on collective efficacy beliefs when implementing participatory interventions. Registration trial DRKS00021138 on the German Registry of Clinical Studies (DRKS), retrospectively registered on 25 March, 2020.
对于职业健康背景下的基于群体的参与性干预措施,目前还没有评估参与者积极参与干预措施的调查问卷。本研究基于集体效能信念的构建,开发了一个调查问卷,用以评估与群体相关的效能信念,这是参与者积极参与参与性干预措施的前提条件。参与者是从一项两臂群组随机干预研究中抽取出来填写问卷的。进行了因子分析和初步心理测量校准。在第二步中,使用多层次分析验证了问卷的群体相关特性。问卷的因子结构与 A. Bandura 的效能信念理论一致。此外,如果工作场所的社会心理环境中缺乏认可和支持,干预措施的参与者的集体效能期望会降低。通过集体效能评估参与式干预中参与者的干预活动质量,可以帮助我们了解干预活动的数量。此外,在实施参与性干预措施时,建议考虑工作场所社会心理环境对集体效能信念的影响。在德国临床试验注册处(DRKS)上注册的回顾性临床试验 DRKS00021138,于 2020 年 3 月 25 日注册。